A tortura da economia moderada"

Explorando o mundo dos sujeitos de pesquisa profissionais e suas implicações éticas

Translated title of the contribution: The "mild-torture economy": Exploring the world of professional research subjects and its ethical implications

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This paper documents the emergence of the subject of professional research in Phase I clinical trials that test the safety of drugs in development. Based on ethnographic research among subjects self-identified as "professional guinea pigs" in Philadelphia, USA, it examines their experiences and opinions on the conduct of trials and risks they take. The author argues that the risks posed by the continued participation, such as exposure to potentially dangerous drug interactions are minimized or ignored by research subjects because of the prospect of financial gain. Risks to the professional guinea pigs are also ignored by the pharmaceutical industry, which has become dependent on the usual participation of experienced research subjects. Arguing that financial incentives undermine the ethical imperative of informed consent to be given freely by volunteers, this research confirms the need to reform the policies governing the participation of paid subjects in Phase I clinical trials.

Original languagePortuguese
Pages (from-to)709-728
Number of pages20
JournalPhysis
Volume25
Issue number3
DOIs
StatePublished - Jul 1 2015

Fingerprint

Torture
Research Subjects
torture
Clinical Trials, Phase I
economy
Guinea Pigs
Research
Guinea
Drug Industry
participation
Informed Consent
Drug Interactions
Motivation
Volunteers
drug
pharmaceutical industry
Safety
Pharmaceutical Preparations
incentive
reform

Keywords

  • Clinical trials
  • Ethics
  • Human subjects
  • Qualitative research
  • Risk

ASJC Scopus subject areas

  • Health(social science)
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

A tortura da economia moderada" : Explorando o mundo dos sujeitos de pesquisa profissionais e suas implicações éticas. / Abadie, Roberto.

In: Physis, Vol. 25, No. 3, 01.07.2015, p. 709-728.

Research output: Contribution to journalArticle

@article{e6a632f62efa475baea3acd784199c00,
title = "A tortura da economia moderada{"}: Explorando o mundo dos sujeitos de pesquisa profissionais e suas implica{\cc}{\~o}es {\'e}ticas",
abstract = "This paper documents the emergence of the subject of professional research in Phase I clinical trials that test the safety of drugs in development. Based on ethnographic research among subjects self-identified as {"}professional guinea pigs{"} in Philadelphia, USA, it examines their experiences and opinions on the conduct of trials and risks they take. The author argues that the risks posed by the continued participation, such as exposure to potentially dangerous drug interactions are minimized or ignored by research subjects because of the prospect of financial gain. Risks to the professional guinea pigs are also ignored by the pharmaceutical industry, which has become dependent on the usual participation of experienced research subjects. Arguing that financial incentives undermine the ethical imperative of informed consent to be given freely by volunteers, this research confirms the need to reform the policies governing the participation of paid subjects in Phase I clinical trials.",
keywords = "Clinical trials, Ethics, Human subjects, Qualitative research, Risk",
author = "Roberto Abadie",
year = "2015",
month = "7",
day = "1",
doi = "10.1590/S0103-73312015000300003",
language = "Portuguese",
volume = "25",
pages = "709--728",
journal = "Physis",
issn = "0103-7331",
publisher = "Institute de Medicina Social da UERJ",
number = "3",

}

TY - JOUR

T1 - A tortura da economia moderada"

T2 - Explorando o mundo dos sujeitos de pesquisa profissionais e suas implicações éticas

AU - Abadie, Roberto

PY - 2015/7/1

Y1 - 2015/7/1

N2 - This paper documents the emergence of the subject of professional research in Phase I clinical trials that test the safety of drugs in development. Based on ethnographic research among subjects self-identified as "professional guinea pigs" in Philadelphia, USA, it examines their experiences and opinions on the conduct of trials and risks they take. The author argues that the risks posed by the continued participation, such as exposure to potentially dangerous drug interactions are minimized or ignored by research subjects because of the prospect of financial gain. Risks to the professional guinea pigs are also ignored by the pharmaceutical industry, which has become dependent on the usual participation of experienced research subjects. Arguing that financial incentives undermine the ethical imperative of informed consent to be given freely by volunteers, this research confirms the need to reform the policies governing the participation of paid subjects in Phase I clinical trials.

AB - This paper documents the emergence of the subject of professional research in Phase I clinical trials that test the safety of drugs in development. Based on ethnographic research among subjects self-identified as "professional guinea pigs" in Philadelphia, USA, it examines their experiences and opinions on the conduct of trials and risks they take. The author argues that the risks posed by the continued participation, such as exposure to potentially dangerous drug interactions are minimized or ignored by research subjects because of the prospect of financial gain. Risks to the professional guinea pigs are also ignored by the pharmaceutical industry, which has become dependent on the usual participation of experienced research subjects. Arguing that financial incentives undermine the ethical imperative of informed consent to be given freely by volunteers, this research confirms the need to reform the policies governing the participation of paid subjects in Phase I clinical trials.

KW - Clinical trials

KW - Ethics

KW - Human subjects

KW - Qualitative research

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=84946059796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946059796&partnerID=8YFLogxK

U2 - 10.1590/S0103-73312015000300003

DO - 10.1590/S0103-73312015000300003

M3 - Article

VL - 25

SP - 709

EP - 728

JO - Physis

JF - Physis

SN - 0103-7331

IS - 3

ER -